Comparative lipidomics of azole sensitive and resistant clinical isolates of candida albicans reveals unexpected diversity in molecular lipid imprints

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Singh, Ashutosh ^a   Prasad, Rajendra ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CACDR1P PROTEIN; CAMDR1P PROTEIN; CHOLESTEROL ESTER; GLYCEROPHOSPHOLIPID; LIPIDOME; MANNOSYLINOSITOL PHOSPHORYLCERAMIDE; MONOUNSATURATED FATTY ACID; PHOSPHATIDYLSERINE; POLYUNSATURATED FATTY ACID; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; CERAMIDE; ESTER; LIPID; MANNOSE; SPHINGOLIPID; STEROL;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; LIPID METABOLISM; LIPIDOMICS; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PROTEIN EXPRESSION; AUTOMATION; BIOCHEMISTRY; CHEMISTRY; HOMEOSTASIS; METABOLISM; METHODOLOGY; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY;

CANDIDA; CANDIDA ALBICANS;

AUTOMATION; BIOCHEMISTRY; CANDIDA ALBICANS; CERAMIDES; ESTERS; HOMEOSTASIS; LIPID METABOLISM; LIPIDS; MANNOSE; MODELS, STATISTICAL; PHOSPHATIDYLSERINES; PRINCIPAL COMPONENT ANALYSIS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPHINGOLIPIDS; STEROLS; TANDEM MASS SPECTROMETRY;

EID: 79955777587     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019266     Document Type: Article

References (53)

1. Richardson MD, (2005) Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56: i5-i11.
2. Pfaller MA, Diekema DJ, (2007) Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem. Clinical Microbiology Reviews 20: 133-163.
3. Clark TA, Hajjeh RA, (2002) Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 15: 569-574.
4. Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, et al. (2006) Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27: 359-366.
5. Prasad R, Kapoor K, (2005) Multidrug resistance in yeast Candida. Int Rev Cytol 242: 215-248.
6. White TC, Marr KA, Bowden RA, (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clinical Microbiology Reviews 11: 382-402.
7. Sanglard D, Coste A, Ferrari S, (2009) Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9: 1029-1050.
8. Sanglard D, White TC, (2005) Chapter 14-Molecular Principles of Antifungal Drug Resistance. In: Heitman J, Filler SG, Edwards JE, Mitchell AP, editors. Molecular principles of fungal pathogenesis Washington, D.C. ASM Press pp. 197-212.
9. Pasrija R, Panwar SL, Prasad R, (2008) Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts. Antimicrob Agents Chemother 52: 694-704.
10. Mukhopadhyay K, Prasad T, Saini P, Pucadyil TJ, Chattopadhyay A, et al. (2004) Membrane Sphingolipid- Ergosterol interactions are important determinants of Multidrug Resistance in Candida albicans. Antimicrob Agents Chemother 48: 1778-1787.
11. Pasrija R, Prasad T, Prasad R, (2005) Membrane raft lipid constituents affect drug susceptibilities of Candida albicans. Biochem Soc Trans 33: 1219-1223.
12. Morschhauser J, (2002) The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 1587: 240-248.
13. Marie C, White TC, (2009) Genetic Basis of Antifungal Drug Resistance. Curr Fungal Infect Rep 3: 163-169.
14. Kohli A, Smriti, Mukhopadhyay K, Rattan A, Prasad R, (2002) In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob Agents Chemother 46: 1046-1052.
15. Mukhopadhyay K, Kohli A, Prasad R, (2002) Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob Agents Chemother 46: 3695-3705.
16. Wenk MR, (2005) The emerging field of lipidomics. Nat Rev Drug Discov 4: 594-610.
17. Watson AD, (2006) Lipidomics: A global approach to lipid analysis in biological systems. J Lipid Res 47: 2101-2111.
18. Bleijerveld OB, Houweling M, Thomas MJ, Cui Z, (2006) Metabolipidomics: profiling metabolism of glycerophospholipid species by stable isotopic precursors and tandem mass spectrometry. Anal Biochem 352: 1-14.
19. Roberts LD, McCombie G, Titman CM, Griffin JL, (2008) A matter of fat: an introduction to lipidomic profiling methods. J Chromatogr B Anal Technol Biomed Life Sci 871: 174-181.
20. Ejsing CS, Sampaio JL, Surendranath V, Duchoslav E, Ekroos K, et al. (2009) Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry. Proc Natl Acad Sci USA 106: 2136-2141.
21. Hitchcock CA, Barrett-Bee KJ, Russell NJ, (1986) The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. J Gen Microbiol 132: 2421-2431.
22. Loffler J, Einsele H, Hebart H, Schumacher U, Hrastnik C, et al. (2000) Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol Lett 185: 59-63.
23. Bligh EG, Dyer WJ, (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.
24. Devaiah SP, Roth MR, Baughman E, Li M, Tamura P, et al. (2006) Quantitative profiling of polar glycerolipid species from organs of wild-type Arabidopsis and a phospholipase Dalpha1 knockout mutant. Phytochemistry 67: 1907-1924.
25. Singh A, Prasad T, Kapoor K, Mandal A, Roth M, et al. (2010) Phospholipidome of Candida: each species of Candida has distinctive phospholipid molecular species. OMICS 14: 665-677.
26. Welti R, Li W, Li M, Sang Y, Biesiada H, et al. (2002) Profiling membrane lipids in plant stress responses. Role of phospholipase D alpha in freezing-induced lipid changes in Arabidopsis. J Biol Chem 277: 31994-32002.
27. Franz R, Ruhnke M, Morschhauser J, (1999) Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42: 453-458.
28. Karababa M, Coste AT, Rognon B, Bille J, Sanglard D, (2004) Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters. Antimicrob Agents Chemother 48: 3064-3079.
29. Franz R, Kelly SL, Lamb DC, Kelly DE, Ruhnke M, et al. (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 42: 3065-3072.
30. Wisching S, Michel S, Morschhauser J, (2000) Target gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol Microbiol 36: 856-865.
31. Han X, Gross RW, (1994) Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc Natl Acad Sci USA 91: 10635-10639.
32. Shevchenko A, Simons K, (2010) Lipidomics: coming to grips with lipid diversity. Nat Rev Mol Cell Biol 11: 593-598.
33. Ringner M, (2008) What is principal component analysis? Nat Biotechnol 26: 303-304.
34. Ferreira CR, Saraiva SA, Catharino RR, Garcia JS, Gozzo FC, et al. (2010) Single embryo and oocyte lipid fingerprinting by mass spectrometry. J Lipid Res 51: 1218-1227.
35. Chen YL, Montedonico AE, Kauff an S, Dunlap JR, Menn FM, et al. (2010) Phosphatidylserine synthase and phosphatidylserine decarboxylase are essential for cell wall integrity and virulence in Candida albicans. Mol Microbiol 75: 1112-1132.
36. Batova M, Borecka-Melkusova S, Simockova M, Dzugasova V, Goffa E, et al. (2008) Functional characterization of the CgPGS1 gene reveals a link between mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata. Curr Genet 53: 313-322.
37. Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y, (1980) Activation of calcium and phospholipid dependent protein-kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255: 2273-2276.
38. Takai Y, Kishimoto A, Kikkawa U, Mori T, Nishizuka Y, (1979) Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid dependent protein-kinase system. Biochem Biophys Res Commun 91: 1218-1224.
39. Newton AC, (1993) Interaction of proteins with lipid head groups: lessons from protein kinase C. Annu Rev Biophys Biomol Struct 22: 1-25.
40. Newton AC, Keranen LM, (1994) Phosphatidyl-l-serine is necessary for protein kinase C's high-affinity interaction with diacylglycerol-containing membranes. Biochemistry 33: 6651-6658.
41. Madani S, Hichami A, Legrand A, Belleville J, Khan NA, (2001) Implication of acyl chain of diacylglycerols in activation of different isoforms of protein kinase C. FASEB J 15: 2595-2601.
42. Griner EM, Kazanietz MG, (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281-294.
43. LaFayette SL, Collins C, Zaas AK, Schell WA, Betancourt-Quiroz M, et al. (2010) PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90. PLoS Pathog 6: e1001069 doi:10.1371/journal.ppat.1001069.
44. Cowen LE, (2009) Hsp90 Orchestrates Stress Response Signaling Governing Fungal Drug Resistance. PLoS Pathog 5: e1000471 doi:10.1371/journal.ppat.1000471.
45. Lee AG, (2004) How lipids affect the activities of integral membrane proteins. Biochim Biophys Acta 1666: 62-87.
46. Hunte C, (2005) Specific protein-lipid interactions in membrane proteins. Biochem Soc Trans 33: 938-942.
47. Tate CG, (2001) Overexpression of mammalian integral membrane proteins for structural studies. FEBS Lett 504: 94-98.
48. Wagner S, Bader ML, Drew D, Gier JW, (2006) Rationalizing membrane protein overexpression. TRENDS Biotech 24: 364-371.
49. Gulshan K, Schmidt JA, Shahi P, Moye-Rowley WS, (2008) Evidence for the bifunctional nature of mitochondrial phosphatidylserine decarboxylase: role in Pdr3-dependent retrograde regulation of PDR5 expression. Mol Cell Biol 28 (19): 5851-64.
50. Shahi P, Moye-Rowley WS, (2009) Coordinate control of lipid composition and drug transport activities is required for normal multidrug resistance in fungi. Biochim Biophys Acta 1794 (5): 852-859.
51. Tate CG, (2001) Overexpression of mammalian integral membrane proteins for structural studies. FEBS Lett 504: 94-98.
52. Bogdanov M, Jianzhong Sun J, Kaback HR, Dowhan W, (1996) A phospholipid acts as a chaperone in assembly of a membrane transport protein. J Biol Chem 271: 11615-11618.
53. Bogdanov M, Umeda M, Dowhan W, (1999) Phospholipid-assisted refolding of an integral membrane protein. Minimum structural features for phosphatidylethanolamine to act as a molecular chaperone. J Biol Chem 274: 12339-12345.